The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Apr. 12, 2016

Filed:

Aug. 10, 2011
Applicants:

Jung Hwan Lee, Pohang-si, KR;

Young Chan Chae, Pohang-si, KR;

Youngdong Kim, Pohang-si, KR;

Hyungu Kang, Daegu, KR;

Jong Hun Im, Seoul, KR;

Jong IN Kim, Pohang-si, KR;

Ki Seok Kim, Pohang-si, KR;

Sung Key Jang, Pohang-si, KR;

IL Ung OH, Cheongju-si, KR;

Min Jeong Choi, Seoul, KR;

Won Jun Kang, Goyang-si, KR;

Inventors:

Jung Hwan Lee, Pohang-si, KR;

Young Chan Chae, Pohang-si, KR;

Youngdong Kim, Pohang-si, KR;

Hyungu Kang, Daegu, KR;

Jong Hun Im, Seoul, KR;

Jong In Kim, Pohang-si, KR;

Ki Seok Kim, Pohang-si, KR;

Sung Key Jang, Pohang-si, KR;

Il Ung Oh, Cheongju-si, KR;

Min Jeong Choi, Seoul, KR;

Won Jun Kang, Goyang-si, KR;

Assignees:
Attorney:
Primary Examiner:
Int. Cl.
CPC ...
C12N 15/11 (2006.01); C12N 15/115 (2010.01); A61K 31/7088 (2006.01); G01N 33/574 (2006.01); A61K 47/48 (2006.01);
U.S. Cl.
CPC ...
C12N 15/115 (2013.01); A61K 31/7088 (2013.01); A61K 47/48215 (2013.01); G01N 33/5748 (2013.01); C12N 2310/16 (2013.01); C12N 2310/335 (2013.01); C12N 2310/3535 (2013.01); C12N 2320/30 (2013.01); G01N 2333/71 (2013.01); G01N 2333/91205 (2013.01);
Abstract

Disclosed are a DNA aptamer specifically binding to the Her2 (ERBB2) receptor involved in the onset of breast cancer, a composition for the suppression of cancer metastasis comprising the same as an active ingredient, and a composition for the diagnosis of cancer comprising the same as an active ingredient. Due to its binding mechanism being different from that of the conventional antibody, the aptamer can be effectively used for suppressing cancer metastasis and diagnosing cancer.


Find Patent Forward Citations

Loading…